正在加载公司
Keep exploring
The themes Cardiol Therapeutics is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Drug Manufacturers Specialty and Generic
Graded A or B and worth $2B or more: A first, then the largest.
TAKTakeda Pharmaceutical Company LimitedUS$34.4BA
NBIXNeurocrine Biosciences, Inc.US$16.9BA+
ELANElanco Animal Health IncorporatedUS$13.4BA
KNSAKiniksa Pharmaceuticals International, plcUS$8.2BA+
LQDALiquidia CorporationUS$5.2BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
GEHCGE Healthcare Technologies Inc.2026年10月28日CAGraded C, now A
基于 Cardiol Therapeutics Inc. 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 该公司以 CAD 申报。数字按当前汇率 US$1.00 = 1.4258 CAD 换算为美元，并对所有期间一视同仁——因此增长和利润率属于公司本身，而不是汇率。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
